Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes
The DOI matches its Crossref record; 62 of the 63 references it cites were found in a registry or an index.
Abstract
Microbial modulation of diabetes: Short-chain fatty acids (SCFAs) are produced by various human gut microbes. SCFAs act as an energy source to the colonic epithelium and are also sensed by host signaling pathways that modulate appetite and inflammation. Deficiency of gut SCFAs is associated with type 2 diabetes. Zhao et al. found that adopting a high-fiber diet promoted the growth of SCFA-producing organisms in diabetic humans. The high-fiber diet induced changes in the entire gut microbe community and correlated with elevated levels of glucagon-like peptide-1, a decline in acetylated hemoglobin levels, and improved blood-glucose regulation. Science , this issue p. 1151
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Indeed, gut bacteria respond to a high-fiber diet as guilds rather than taxa, suggesting that guilds may mediate the beneficial effects of dietary fiber on immunotherapy.152”
From Melanoma and microbiota: Current understanding and future directions (2024) · cites this paper as [152]
In the citing paper
“Indeed, gut bacteria respond to a high-fiber diet as guilds rather than taxa, suggesting that guilds may mediate the beneficial effects of dietary fiber on immunotherapy.152”
From Melanoma and microbiota: Current understanding and future directions (2024) · cites this paper as [152]
In the citing paper
“A lower abundance of SCFA-producing bacteria has been associated with higher risk of type 2 diabetes.89”
From Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer (2020) · cites this paper as [89]
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
The Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041
Fast gapped-read alignment with Bowtie 2
Langmead, B., & Salzberg, S. L. (2012) · Nature Methods · doi:10.1038/nmeth.1923 · Cited by 56,400
QIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887
Metagenomic biomarker discovery and explanation
Segata, N., Izard, J., Waldron, L., Gevers, D., Miropolsky, L., Garrett, W. S., & Huttenhower, C. (2011) · Genome Biology · doi:10.1186/gb-2011-12-6-r60 · Cited by 16,192
Prodigal: prokaryotic gene recognition and translation initiation site identification
Hyatt, D., Chen, G.-L., LoCascio, P. F., Land, M. L., Larimer, F. W., & Hauser, L. J. (2010) · BMC Bioinformatics · doi:10.1186/1471-2105-11-119 · Cited by 12,587
Parks, D. H., Imelfort, M., Skennerton, C. T., Hugenholtz, P., & Tyson, G. W. (2015) · Genome Research · doi:10.1101/gr.186072.114 · Cited by 12,496
Velvet: Algorithms for de novo short read assembly using de Bruijn graphs
Zerbino, D. R., & Birney, E. (2008) · Genome Research · doi:10.1101/gr.074492.107 · Cited by 9,491
From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites
Koh, A., De Vadder, F., Kovatcheva-Datchary, P., & Bäckhed, F. (2016) · Cell · doi:10.1016/j.cell.2016.05.041 · Cited by 7,070
A metagenome-wide association study of gut microbiota in type 2 diabetes
Qin, J., Li, Y., Cai, Z., Li, S., Zhu, J., Zhang, F., Liang, S., Zhang, W., Guan, Y., Shen, D., et al. (2012) · Nature · doi:10.1038/nature11450 · Cited by 6,762
Self-citation
Research works printed but not linked: 3
- Chinese Diabetes Society, China guideline for type 2 diabetes (2013 edition). Chin. J. Diabetes Mellitus 6, 447–498 (2014).
- Y. Yang G. Wang X. Pan China Food Composition (Book 1 Beijing Medical Univ. Press ed. 2 2009).
- H. Wu, R. Wang, Y. Zhao, X. Pang, J. Shen, C. Zhang, ., Exploring carbohydrate utilization capacity of Bifidobacterium pseudocatenulatum isolated from a morbidly obese child after dietary intervention. Genomics Appl. Biol. 34, 1384–1391 (2015).
Cited by
Items 301–400 of 1,011
Eriksen, A. K., Brunius, C., Mazidi, M., Hellström, P. M., Risérus, U., Iversen, K. N., Fristedt, R., Sun, L., Huang, Y., Nørskov, N. P., et al. (2020) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqaa026 · Cited by 94
Modulation of Short-Chain Fatty Acids as Potential Therapy Method for Type 2 Diabetes Mellitus
Tang, R., & Li, L. (2021) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2021/6632266 · Cited by 131
“Furthermore, administration of dietary fiber in T2DM patients enhanced a group of SCFA producers and improved glycated hemoglobin levels, partly via increased GLP-1 production, which resulted in T2DM alleviation [13].”
BackgroundThe Therapeutic Effect of SCFA-Mediated Regulation of the Intestinal Environment on Obesity
You, H., Tan, Y., Yu, D., Qiu, S., Bai, Y., He, J., Cao, H., Che, Q., Guo, J., & Su, Z. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.886902 · Cited by 106
“Targeted promotion of SCFA producers as ESPs through personalized nutrition may provide a new ecological approach for controlling gut microbiota to manage dysbiosis-related diseases (115).”
BackgroundWang, Y., Zhao, J., Qin, Y., Yu, Z., Zhang, Y., Ning, X., & Sun, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.908219 · Cited by 110
“DKD is one of the most common and serious complications of diabetes, and the emerging role of its gut microbiota has attracted wide attention and is considered an important factor affecting the occurrence and development of DKD. Studies have shown that the gut microbiome mediated the synthesis, modification, and uptak…”
BackgroundInfluentialGut microbiota dysbiosis in polycystic ovary syndrome: association with obesity—a preliminary report
Liang, Y., Ming, Q., Liang, J., Zhang, Y., Zhang, H., & Shen, T. (2020) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2019-0413 · Cited by 95
Fermented carrot juice attenuates type 2 diabetes by mediating gut microbiota in rats
Hu, R., Zeng, F., Wu, L., Wan, X., Chen, Y., Zhang, J., & Liu, B. (2019) · Food & Function · doi:10.1039/c9fo00475k · Cited by 104
Su, H., Xie, L., Xu, Y., Ke, H., Bao, T., Li, Y., & Chen, W. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b03338 · Cited by 99
Self-citationWu, H., Singer, J., Kwan, T., Loh, Y. W., Wang, C., Tan, J., Li, Y. J., Lai, C., Macia, L., Alexander, S. I., et al. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2019080852 · Cited by 100
Wang, B., Yu, H., He, Y., Lian-kui, W., Gu, J., Wang, X., Miao, X., Qiu, G., & Wang, H. (2021) · Food & Function · doi:10.1039/d1fo00078k · Cited by 96
Self-citationXu, T. C., Wu, X., Liu, J., Sun, J., Wang, X., Fan, G., Meng, X., Zhang, J., & Zhang, Y. (2021) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2021.11.001 · Cited by 98
Self-citationCommensal microbe-derived SCFA alleviates atrial fibrillation via GPR43/NLRP3 signaling
Zuo, K., Chen, F., Liu, Z., Fu, Y., Liu, Y., Liu, L., Wang, Y., Yin, X., Liu, X., Li, J., et al. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.70644 · Cited by 100
“The beneficial effects of SCFA have been demonstrated in several disease models, such as hypertension [14, 15], diabetes [16, 17], multiple sclerosis [18], and stroke [19], wherein the SCFA exerts their effects via natural sensors, such as G-protein-coupled receptor (GPR) 43 [20, 21].”
BackgroundGut microbiome interventions in human health and diseases
Nie, P., Li, Z., Wang, Y., Zhang, Y., Zhao, M., Luo, J., Du, S., Deng, Z., Chen, J., Wang, Y., et al. (2019) · Medicinal Research Reviews · doi:10.1002/med.21584 · Cited by 99
Self-citationFrom role of gut microbiota to microbial-based therapies in type 2-diabetes
Ebrahimzadeh Leylabadlo, H., Sanaie, S., Sadeghpour Heravi, F., Ahmadian, Z., & Ghotaslou, R. (2020) · Infection, Genetics and Evolution · doi:10.1016/j.meegid.2020.104268 · Cited by 92
Wang, J., Qie, J., Zhu, D., Zhang, X., Zhang, Q., Xu, Y., Wang, Y., Mi, K., Pei, Y., Liu, Y., et al. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2107288 · Cited by 91
Self-citationMicrobial Population Changes and Their Relationship with Human Health and Disease
Álvarez‐Mercado, A. I., Navarro-Oliveros, M., Robles-Sánchez, C., Plaza‐Díaz, J., Sáez‐Lara, M. J., Muñoz‐Quezada, S., Fontana, L., & Abadía‐Molina, F. (2019) · Microorganisms · doi:10.3390/microorganisms7030068 · Cited by 104
“observed that a high-fiber diet promoted the growth of SCFA-producing organisms in diabetic humans [147,155].”
BackgroundNovel insights into prebiotic properties on human health: A review
Neri-Numa, I. A., & Pastore, G. M. (2020) · Food Research International · doi:10.1016/j.foodres.2019.108973 · Cited by 96
Probiotic fermentation modifies the structures of pectic polysaccharides from carrot pulp
Wan, Y., Hong, T., Shi, H.-F., Yin, J., Koev, T. T., Nie, S., Gilbert, R. G., & Xie, M. (2020) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2020.117116 · Cited by 98
Protective effects of Poria cocos and its components against cisplatin-induced intestinal injury
Zou, Y., Zhou, J., Wu, C., Zhang, W. K., Shen, H., Xu, J., Zhang, Y., Long, F., & Li, S. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.113722 · Cited by 99
Self-citationTransforming medicine with the microbiome
Zmora, N., Soffer, E., & Elinav, E. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aaw1815 · Cited by 92
Tang, S. N., Tong, Q., Xia, D., Xu, M., Xu, M., Zhu, A., Shen, W., & Lee, H. K. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.9b00255 · Cited by 93
Palmnäs, M. S. A., Brunius, C. F., Shi, L. S., Rostgaard-Hansen, A., Estanyol-Torres, N., González‐Domínguez, R., Zamora‐Ros, R., Ye, Y. L., Halkjær, J., Tjønneland, A. M., et al. (2019) · Advances in Nutrition · doi:10.1093/advances/nmz121 · Cited by 101
Li, Y., Su, X., Gao, Y., Lv, C., Gao, Z., Liu, Y., Wang, Y., Li, S., & Wang, Z. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165764 · Cited by 102
Dietary compounds in modulation of gut microbiota-derived metabolites
Feng, W., Liu, J., Cheng, H., Zhang, D., Tan, Y., & Peng, C. Y. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.939571 · Cited by 108
Álvarez‐Mercado, A. I., & Plaza‐Díaz, J. (2022) · Nutrients · doi:10.3390/nu14194116 · Cited by 107
“This is because the microbes that digest fiber become exclusively enriched, resulting in a change in intestinal composition and, through competitive interactions, decreased diversity [56].”
BackgroundKang, D., Su, M., Duan, Y., & Huang, Y. P. (2019) · Food & Function · doi:10.1039/c9fo00604d · Cited by 97
Liu, J., Segovia, I., Yuan, X., & Gao, Z. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030910 · Cited by 100
“A deficiency in overall SCFA production is also associated with T2D and other diseases [11].”
BackgroundLiu, Y., Gao, Y., Ma, F., Sun, M., Mu, G., & Tuo, Y. (2020) · Food & Function · doi:10.1039/d0fo00439a · Cited by 96
Dietary patterns and cardiometabolic health: Clinical evidence and mechanism
Wang, W., Liu, Y., Li, Y., Luo, B., Lin, Z., Chen, K., & Liu, Y. (2023) · MedComm · doi:10.1002/mco2.212 · Cited by 100
Paoli, A., Bianco, A., Moro, T., Mota, J. F., & Coelho‐Ravagnani, C. D. F. (2023) · Nutrients · doi:10.3390/nu15143120 · Cited by 98
Melanoma and microbiota: Current understanding and future directions
Routy, B., Jackson, T., Mählmann, L., Baumgartner, C. K., Blaser, M., Byrd, A., Corvaia, N., Couts, K., Davar, D., Derosa, L., et al. (2024) · Cancer Cell · doi:10.1016/j.ccell.2023.12.003 · Cited by 89
Self-citationDuan, Y., Wang, Y., Liu, Q., Dong, H., Li, H., Xiong, D., & Zhang, J. (2019) · Scientific Reports · doi:10.1038/s41598-019-42939-8 · Cited by 95
Nie, C., Sun, Y., Zhen, H., Guo, M., Ye, J., Liu, Z., Yang, Y., & Zhang, X. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00438 · Cited by 89
Gut microbiota predicts body fat change following a low-energy diet: a PREVIEW intervention study
Jian, C., Silvestre, M. P., Middleton, D., Korpela, K., Jalo, E., Broderick, D. T. J., de Vos, W. M., Fogelholm, M., Taylor, M. W., Raben, A., et al. (2022) · Genome Medicine · doi:10.1186/s13073-022-01053-7 · Cited by 95
“While greater microbiota diversity does not necessarily imply better health [53], low diversity has been linked to poor metabolic health due to, e.”
BackgroundMills, S., Lane, J. A., Smith, G. J., Grimaldi, K. A., Ross, R. P., & Stanton, C. (2019) · Nutrients · doi:10.3390/nu11071468 · Cited by 88
“Dietary fibres were shown to promote a select group of SCFA-producing bacteria in patients with type 2 diabetes [241].”
BackgroundXiao, S., Jiang, S., Qian, D., & Duan, J. (2019) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-019-10312-4 · Cited by 96
Du, S., Kim, H., Crews, D. C., White, K., & Rebholz, C. M. (2022) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2022.03.016 · Cited by 83
dbCAN-seq update: CAZyme gene clusters and substrates in microbiomes
Zheng, J., Hu, B., Zhang, X., Ge, Q., Yan, Y., Akresi, J. E., Piyush, V., Huang, L., & Yin, Y. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac1068 · Cited by 92
“It is now possible to infer carbohydrate substrates for CAZymes and CGCs, which is of a huge interest to applied microbiome (18,19).”
BackgroundLiu, Y., Pei, Z., Pan, T., Wang, H., Chen, W., & Lu, W. (2023) · Microbiological Research · doi:10.1016/j.micres.2023.127392 · Cited by 89
Recent insights into the nutritional immunomodulation of cancer‐related microRNAs
Şahin, T. Ö., Yılmaz, B., Yeşilyurt, N., Cicia, D., Szymanowska, A., Amero, P., Ağagündüz, D., & Capasso, R. (2023) · Phytotherapy Research · doi:10.1002/ptr.7937 · Cited by 91
“Considering the skill of changing the gene expression in a host cell, therapeutic targeting of microbiota is seen among the new approaches for the prevention and treatment of cancer (Gao et al., 2021; Zhao et al., 2018).”
BackgroundCui, H., Zhang, L.-S., Luo, Y., Yuan, K., Huang, Z.-Y., & Guo, Y. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01423 · Cited by 94
The Role of the Gut Microbiome in Energy Balance With a Focus on the Gut-Adipose Tissue Axis
Xiao, H., & Kang, S. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00297 · Cited by 82
Yang, Q., Ouyang, J., Sun, F., & Yang, J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.590685 · Cited by 90
Hughes, R., Horn, W. H., Finnegan, P., Newman, J. W. I., Marco, M. L., Keim, N. L., & Kable, M. E. (2021) · Nutrients · doi:10.3390/nu13020645 · Cited by 93
“The enrichment of specific taxa, including Faecalibacterium and Bifidobacterium, and associated metabolic changes such as production of SCFAs have been shown to improve metabolic indices of type 2 diabetes [41].”
BackgroundMolecular and Pathophysiological Links between Metabolic Disorders and Inflammatory Bowel Diseases
Hyun, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179139 · Cited by 90
Jin, H., You, L., Zhao, F., Li, S., Ma, T., Kwok, L. Y., Xu, H., & Sun, Z. (2022) · Gut Microbes · doi:10.1080/19490976.2021.2021790 · Cited by 100
Button, J. E., Autran, C. A., Reens, A. L., Cosetta, C. M., Smriga, S., Ericson, M., Pierce, J. V., Cook, D. N., Lee, M. L., Sun, A. K., et al. (2022) · Cell Host & Microbe · doi:10.1016/j.chom.2022.04.001 · Cited by 86
Ivashkin, V. T., Maevskaya, M. V., Жаркова, М. С., Kotovskaya, Y. V., Ткачева, О. Н., Troshina, E. A., Shestakova, M. V., Maev, I. V., Breder, V. V., Geyvandova, N. I., et al. (2022) · Russian Journal of Gastroenterology Hepatology Coloproctology · doi:10.22416/1382-4376-2022-32-4-104-140 · Cited by 101
Our extended microbiome: The human-relevant metabolites and biology of fermented foods
Caffrey, E. B., Sonnenburg, J. L., & Devkota, S. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.03.007 · Cited by 89
Breuninger, T. A., Wawro, N., Breuninger, J., Reitmeier, S., Clavel, T., Six-Merker, J., Pestoni, G., Rohrmann, S., Rathmann, W., Peters, A., et al. (2021) · Microbiome · doi:10.1186/s40168-020-00969-9 · Cited by 93
“prausnitzii, often as a result of modulation with a high-fiber diet, to be associated with improvement in T2DM parameters [19, 60, 61].”
BackgroundThe human microbiome encodes resistance to the antidiabetic drug acarbose
Balaich, J. N., Estrella, M. A., Wu, G. G., Jeffrey, P. D., Biswas, A. G., Zhao, L., Korennykh, A. V., & Donia, M. S. (2021) · Nature · doi:10.1038/s41586-021-04091-0 · Cited by 90
Self-citationFu, L., Zhang, G., Qian, S., Zhang, Q., & Tan, M. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.972399 · Cited by 93
“Emerging evidence has shown that dietary fiber can be fermented by gut microbiota to produce short-chain fatty acids (SCFAs), and eventually, humans, especially patients with T2DM, can benefit from the increased level of SCFAs (86).”
BackgroundSelf-citationPuig‐Castellví, F., Pacheco‐Tapia, R., Deslande, M., Jia, M., Andrikopoulos, P., Chechi, K., Bonnefond, A., Froguel, P., & Dumas, M. (2023) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2023.117248 · Cited by 91
(2020) · doi:10.1016/j.gpb.2020.06.011 · Cited by 84
Interaction between gut microbiota and ethnomedicine constituents
Wu, X., & Tan, R. X. (2019) · Natural Product Reports · doi:10.1039/c8np00041g · Cited by 85
Dietary κ-carrageenan facilitates gut microbiota-mediated intestinal inflammation
Wu, W., Zhou, J., Xuan, R., Chen, J., Han, H. L., Liu, J., Niu, T., Chen, H., & Wang, F. (2021) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2021.118830 · Cited by 89
Zhang, C., Jiang, J., Wang, C., Li, S., Yu, L., Tian, F., Zhao, J., Zhang, H., Chen, W., & Zhai, Q. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.11.037 · Cited by 87
Self-citationEngineering the gut microbiome
Bai, X., Huang, Z., Duraj‐Thatte, A., Ebert, M., Zhang, F., Burgermeister, E., Liu, X., Scott, B. M., Li, G., & Zuo, T. (2023) · Nature Reviews Bioengineering · doi:10.1038/s44222-023-00072-2 · Cited by 92
Self-citationCirculating Metabolites Originating from Gut Microbiota Control Endothelial Cell Function
Amedei, A., & Morbidelli, L. (2019) · Molecules · doi:10.3390/molecules24213992 · Cited by 89
“Additionally, dietary fiber can selectively increase the abundance of SCFA-producing bacteria [86].”
BackgroundYang, H., Bao, J., Qi, Y., Zhao, J., Hu, Y., Wu, W., Wu, X., Zhong, D., Huo, D., & Hou, C. (2020) · Analytica Chimica Acta · doi:10.1016/j.aca.2020.08.010 · Cited by 83
Intestinal microbial metabolites in human metabolism and type 2 diabetes
Herrema, H., & Niess, J. H. (2020) · Diabetologia · doi:10.1007/s00125-020-05268-4 · Cited by 87
“In a study by Zhao and co-workers, participants with type 2 diabetes were administered large amounts of dietary fibres [120].”
BackgroundThe Role of Nutrition in the Prevention and Intervention of Type 2 Diabetes
Guo, Y., Huang, Z., Sang, D., Gao, Q., & Li, Q. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.575442 · Cited by 90
Role and Treatment of Insulin Resistance in Patients with Chronic Kidney Disease: A Review
Nakashima, A., Kato, K., Ohkido, I., & Yokoo, T. (2021) · Nutrients · doi:10.3390/nu13124349 · Cited by 90
“Short-chain fatty acids produced by the breakdown of dietary fiber caused by intestinal bacteria promote energy consumption and increase appetite-suppressing hormones [67].”
BackgroundDietary manipulation of the gut microbiome in inflammatory bowel disease patients: Pilot study
Olendzki, B. C., Bucci, V., Cawley, C., Maserati, R., McManus, M. M., Olednzki, E., Madziar, C., Chiang, D., Ward, D. V., Pellish, R. S., et al. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2046244 · Cited by 86
“These results suggest that specific foods affect the abundance of bacteria at the species level and are consistent with previous studies.(33,48,49) In subjects with UC, similar results were observed.”
ResultCancello, R., Turroni, S., Rampelli, S., Cattaldo, S., Candela, M., Cattani, L., Mai, S., Vietti, R., Scacchi, M., Brigidi, P., et al. (2019) · Nutrients · doi:10.3390/nu11123011 · Cited by 88
“In light of the role of diet as a pivotal determinant of gut microbiota structure and function [20], targeted microbiota manipulation via nutritional interventions has recently been promoted as a novel ecological approach for the prevention and treatment of obesity and related metabolic disorders, as well as potential…”
BackgroundJing, N., Liu, X., Jin, M., Yang, X., Hu, X., Li, C., & Zhao, K. (2020) · Food & Function · doi:10.1039/d0fo01282c · Cited by 87
Proteomics, metabolomics and metagenomics for type 2 diabetes and its complications
Wang, N., Zhu, F., Chen, L., & Chen, K. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.09.035 · Cited by 91
Friend or foe? The roles of inulin-type fructans
Man, S., Liu, T., Yao, Y., Lu, Y., Ma, L., & Lu, F. (2020) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2020.117155 · Cited by 90
Dietary fiber and chicken microbiome interaction: Where will it lead to?
Mahmood, T., & Guo, Y. (2019) · Animal nutrition · doi:10.1016/j.aninu.2019.11.004 · Cited by 97
“The individual animal may lack some “keystone” species or strains that possess a specific set of enzymes to degrade a specific substrate (Zhao et al., 2018).”
BackgroundWang, R., Wang, L., Wang, S., Wang, J., Su, C., Zhang, L., Li, C., & Liu, S. (2022) · Food Chemistry · doi:10.1016/j.foodchem.2022.134232 · Cited by 82
Self-citationProbiotics for the treatment of depression and its comorbidities: A systemic review
Gao, J., Zhao, N., Cheng, Y., Lei, W., Wang, Y., Liu, X., Zheng, N., Shao, L., Chen, X., Sun, Y., et al. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1167116 · Cited by 87
“Preclinical studies and clinical trials suggest that modifying the composition of the gut microbiota via probiotic supplementation have been proven to be beneficial in treating or preventing human diseases (Zhao et al., 2018; Sanders et al., 2019; Edwards et al., 2020; Sun et al., 2021), which may be a viable adjuvant…”
BackgroundZhao, C., Dong, H., Zhang, Y., & Li, Y. (2019) · npj Biofilms and Microbiomes · doi:10.1038/s41522-019-0092-7 · Cited by 80
Yuan, Y., Zheng, Y., Zhou, J., Geng, Y., Zou, P., Li, Y., & Zhang, C. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b05118 · Cited by 85
Self-citationJensen, E., Young, J. A., Mathes, S. C., List, E. O., Carroll, R. K., Kuhn, J., Onusko, M., Kopchick, J. J., Murphy, E. R., & Berryman, D. E. (2020) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2020.101333 · Cited by 86
Wang, Y., Nan, X., Zhao, Y., Jiang, L., Wang, H., Hua, D., Zhang, F., Wang, Y., Liu, J., Yao, J., et al. (2021) · Animal nutrition · doi:10.1016/j.aninu.2021.09.007 · Cited by 84
Self-citationWang, R., Wang, L., Wu, H., Zhang, L., Hu, X., Li, C., & Liu, S. (2022) · Food Research International · doi:10.1016/j.foodres.2022.111732 · Cited by 86
Self-citationApproach to the diagnosis and management of dysbiosis
Alagiakrishnan, K., Morgadinho, J., & Halverson, T. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1330903 · Cited by 91
“Dietary fiber has been shown in randomized controlled trial (RCT) to promote the growth of SCFAs producing bacteria which may impact type 2 diabetes management (236).”
BackgroundTargeting Carbohydrates and Polyphenols for a Healthy Microbiome and Healthy Weight
Hul, M. V., & Cani, P. D. (2019) · Current Nutrition Reports · doi:10.1007/s13668-019-00281-5 · Cited by 87
High-Fat Diet Alters the Intestinal Microbiota in Streptozotocin-Induced Type 2 Diabetic Mice
Liu, S., Qin, P., & Wang, J. (2019) · Microorganisms · doi:10.3390/microorganisms7060176 · Cited by 85
“changes in the entire gut microbe community that is associated with improved blood-glucose regulation in T2D [11].”
BackgroundSelf-citationSwanson, K. S., de Vos, W. M., Martens, E. C., Gilbert, J. A., Menon, R. S., Soto‐Vaca, A., Hautvast, J., Meyer, P., Borewicz, K., Vaughan, E. E., et al. (2020) · Beneficial Microbes · doi:10.3920/bm2019.0082 · Cited by 92
“13 9 K.S. Swanson et al. 122 Beneficial Microbes 11(2) improved blood-glucose regulation (Zhao et al., 2018).”
BackgroundZhao, B., Zeng, L., Zhao, J., Wu, Q., Dong, Y., Zou, F., Gan, L., Wei, Y., & Zhang, W. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-032240 · Cited by 87
Bioavailability Based on the Gut Microbiota: a New Perspective
Zhang, F., He, F., Li, L., Guo, L., Zhang, B., Yu, S., & Zhao, W. (2020) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00072-19 · Cited by 82
“Notably, an elevation of an index based on mathematical modeling of the 15 SCFA producers could predict a reduction in glycosylated hemoglobin (HbA1c, an important glycometabolism parameter), indicating significant roles of the SCFAs derived from beneficial gut bacteria during the alleviation of T2DM (18).”
BackgroundInfluentialSelf-citationProbiotics for Neurodegenerative Diseases: A Systemic Review
Ojha, S., Patil, N., Jain, M., Kole, C., & Kaushik, P. (2023) · Microorganisms · doi:10.3390/microorganisms11041083 · Cited by 88
“Bulbar function slowly deteriorated with the progression of the disease, and dysphagia (because of aspiration pneumonia and weight loss) have seen [48].”
BackgroundThe equine gastrointestinal microbiome: impacts of weight-loss
Morrison, P. K., Newbold, C. J., Jones, E., Worgan, H. J., Grove‐White, D., Dugdale, A., Barfoot, C. F., Harris, P. A., & Argo, C. M. (2020) · BMC Veterinary Research · doi:10.1186/s12917-020-02295-6 · Cited by 83
Simplified Intestinal Microbiota to Study Microbe-Diet-Host Interactions in a Mouse Model
Kovatcheva-Datchary, P., Shoaie, S., Lee, S., Wahlström, A., Nookaew, I., Hallen, A., Perkins, R., Nielsen, J., & Bäckhed, F. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.02.090 · Cited by 79
“, 2016) but also affect host physiology (Koh et al., 2016; Zhao et al., 2018).”
BackgroundEffects of polysaccharide from Pueraria lobata on gut microbiota in mice
Chen, R., Liu, B., Wang, X., Chen, K., Zhang, K., Zhang, L., Fei, C., Wang, C., Liu, Y., Xue, F., et al. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.04.201 · Cited by 84
Self-citationWhat we know about protein gut metabolites: Implications and insights for human health and diseases
Rodríguez-Romero, J. D. J., Durán-Castañeda, A. C., Cárdenas-Castro, A. P., Sánchez-Burgos, J. A., Zamora-Gasga, V. M., & Sáyago‐Ayerdi, S. G. (2021) · Food Chemistry X · doi:10.1016/j.fochx.2021.100195 · Cited by 97
Alternative stable states, nonlinear behavior, and predictability of microbiome dynamics
Fujita, H., Ushio, M., Suzuki, K. T., Abe, M., Yamamichi, M., Iwayama, K., Canarini, A., Hayashi, I., Fukushima, K., Fukuda, S., et al. (2023) · Microbiome · doi:10.1186/s40168-023-01474-5 · Cited by 84
“Managing the compositions of human gut microbiomes, for example, is essential for preventing diabetes [8, 9], infectious disease [10], and neuropsychiatric disorders [11].”
BackgroundThe gut microbiota promotes the pathogenesis of schizophrenia via multiple pathways
Yuan, X., Kang, Y., Zhuo, C., Huang, X.-F., & Song, X. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.02.152 · Cited by 73
Zheng, J., Zheng, S.-J., Cai, W., Yu, L., Yuan, B., & Feng, Y. (2019) · Analytica Chimica Acta · doi:10.1016/j.aca.2019.04.021 · Cited by 80
Self-citationXue, Z., Ma, Q., Chen, Y., Lu, Y., Wang, Y., Jia, Y., Zhang, M., & Chen, H. (2019) · Food Research International · doi:10.1016/j.foodres.2019.108870 · Cited by 77
Self-citationSargassum fusiforme polysaccharide partly replaces acarbose against type 2 diabetes in rats
Li, Z., Jia, R., Wu, J., Lin, L., Ou, Z.-R., Liao, B., Zhang, L., Zhang, X., Song, G., & Zhao, M. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.12.126 · Cited by 76
Polysaccharides influence human health via microbiota-dependent and -independent pathways
Gan, L., Wang, J., & Guo, Y. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1030063 · Cited by 81
“Dietary polysaccharides enriched the SCFA-producing strains in the intestine, including Bifidobacterium and Romboutsia, thus enhancing SCFAs concentrations, inhibiting the growth of other detrimental bacteria, and benefiting T2DM patients (104, 108).”
BackgroundSelf-citationTang, X., & de Vos, P. (2023) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2023.2290230 · Cited by 82
“…Ruminococcaceae , Succinivibrionaceae , Lachnospiraceae and Bacteroidaceae by supporting the adhesion of microbial cells to small intestinal cells (Zhao et al. 2018) and by stimulating production of fermentation products short-chain fatty acids (SCFAs) such as acetic and butyric acid (Bianchi et…”
Gut Microbiota and Blood Metabolites Related to Fiber Intake and Type 2 Diabetes
Wang, Z., Peters, B. A., Yu, B., Grove, M. L., Wang, T., Xue, X., Thyagarajan, B., Daviglus, M. L., Boerwinkle, E., Hu, G., et al. (2024) · Circulation Research · doi:10.1161/circresaha.123.323634 · Cited by 79
Self-citationIntestinal Microbiota Is Altered in Patients with Gastric Cancer from Shanxi Province, China
Qi, Y.-F., Sun, J., Ren, L., Cao, X.-L., Dong, J.-H., Tao, K. X., Guan, X., Cui, Y.-N., & Su, W. (2018) · Digestive Diseases and Sciences · doi:10.1007/s10620-018-5411-y · Cited by 81
Qian, X., Liu, Y., Ye, X., Zheng, W. J., Lv, S., Mo, M., Lin, J., Wang, W., Wang, W., Zhang, X., et al. (2020) · BMC Genomics · doi:10.1186/s12864-020-6703-0 · Cited by 83
“Although causal relationships among gut microbiota, SCFAs, and metabolic diseases have been demonstrated previously [22, 56], these relationships remain vague in JIA and need to be further investigated.”
BackgroundBurz, S. D., Monnoye, M., Philippe, C., Farin, W., Ratziu, V., Strozzi, F., Paillarse, J.-M., Chêne, L., Blottière, H. M., & Gérard, P. (2021) · Microorganisms · doi:10.3390/microorganisms9010199 · Cited by 69
Zhu, J., Wu, M., Zhou, H. J., Cheng, L., Wei, X., & Wang, Y. (2021) · Food Research International · doi:10.1016/j.foodres.2021.110594 · Cited by 79
Fecal Transplantation from db/db Mice Treated with Sodium Butyrate Attenuates Ischemic Stroke Injury
Wang, H., Song, W., Wu, Q., Gao, X., Li, J., Tan, C., Zhou, H., Zhu, J., He, Y., & Yin, J. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.00042-21 · Cited by 79
Xie, C., Qi, C., Zhang, J., Wang, W., Meng, X., Aikepaer, A., Lin, Y., Su, C., Liu, Y., Feng, X., et al. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.116791 · Cited by 77
Metadata
- Authors
- Zhao, L., Zhang, F., Ding, X., Wu, G., Lam, Y. Y., Wang, X., Fu, H., Xue, X., Lu, C., Ma, J., Yu, L., Xu, C., Ren, Z., Xu, Y., Xu, S., Shen, H., Zhu, X., Shi, Y., Shen, Q., Dong, W., Liu, R., Ling, Y., Zeng, Y., Wang, X., Zhang, Q., Wang, J., Wang, L., Wu, Y., Zeng, B., Wei, H., Zhang, M., Peng, Y., & Zhang, C.
- Affiliations
- Rutgers, The State University of New Jersey (US)
- Shanghai Jiao Tong University (CN)
- Sijing Community Health Service Center of Songjiang District, Shanghai 201601, China.
- Sijing Hospital of Songjiang District, Shanghai 201601, China.
- Department of Endocrinology and Metabolism, Qidong People’s Hospital, Jiangsu 226200, China.
- Army Medical University (CN)
- Corresponding author
- Zhao, Liping
- Zhang, Feng
- Ding, Xiaoying
- Wu, Guojun
- Lam, Yan Y.
- Peng, Yongde
- Zhang, Chenhong
- ORCID
- Venue
- Science
- Published
- 2018-03-09
- Volume
- 359
- Issue
- 6380
- Pages
- 1151-1156
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2789495752
- Cited by
- 2,304
- References
- 63
- Citations by year
- 2026: 208 · 2025: 286 · 2024: 270 · 2023: 301 · 2022: 347 · 2021: 307 · 2020: 285 · 2019: 216 · 2018: 81
- FWCI
- 79.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (31330005, 81401141, 81370904)
- Science and Technology Commission of Shanghai Municipality (14YF1402200)
- Key Projects of Shanghai Municipal Health Bureau Research Fund (201440033)
- Shanghai Jiao Tong University Research Funding on Medical and Engineering Interdisciplinary Projects (YG2015ZD08)
- Songjiang District Health Bureau of Climbing Medical Program (0702N14003)
- Shanghai Shen Kang Hospital Development Center for chronic disease prevention and control project (SHDC12015304)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Nursing › Nutrition and Dietetics › Microbial Metabolites in Food Biotechnology
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- type 2 diabetes, gut microbiota, dietary fiber, short-chain fatty acids, SCFA-producing bacteria, fecal microbiota transplantation, glucagon-like peptide-1, HbA1c, indole, hydrogen sulfide, carbohydrate fermentation, isocaloric diet
- MeSH terms
- Gastrointestinal Microbiome, Adult, Aged, Bacteria, China, Diabetes Mellitus, Type 2, Diet, Dietary Fiber, Fatty Acids, Volatile, Feces, Female, Fermentation, Glycated Hemoglobin, Humans, Hydrogen Sulfide, Indoles, Male, Middle Aged, Glucagon-Like Peptide 1, Metagenomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.